Just reported
From Zimmer Biomet's results release of 4 november 2026; its quarterly report has since been filed.
Actual
US$ 2,06B
+3,1% y/y
-5,2% q/q
Guided
—
No guide given
Actual
US$ 1,00
-14% y/y
-2,9% q/q
Guided
—
No guide given
Actual
US$ 307,6M
-12% y/y
-5,7% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
De omzetaandelen zijn schattingen voor six months ended June 30, 2026, geen cijfers uit een ingediend rapport.
Knee replacement implants
Artificial parts that replace all or part of a damaged knee, including components used in later repair or replacement procedures.
Hip replacement systems
Artificial parts that replace the ball and socket of the hip; some are fixed with bone cement and others are designed to attach directly to bone.
Sports medicine, extremities and trauma devices
Devices used to repair soft-tissue injuries, stabilize broken bones, and treat conditions in the foot, ankle, shoulder, elbow and wrist.
ROSA Robot
A surgical robot that helps surgeons position implants during certain knee, hip and shoulder procedures.
ZBEdge
A group of robotic and digital technologies that gathers information before, during and after surgery to help inform patient care.
Bone cement
Cement and related mixing and delivery products used to attach some orthopedic implants to bone.
Zimmer Biomet makes artificial knees and hips, as well as devices used to repair injuries to bones, joints, and surrounding soft tissue. Surgeons use its ROSA robot to help position implants during some operations. Hospitals and surgery centers buy products directly or through distributors and dealers; many products are kept on consignment for use when a procedure is scheduled.
Gebouwd uit de eigen deponeringen van Zimmer Biomet Holdings, Inc. bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
The themes Zimmer Biomet is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$ 103,19-1,4%slot 13 nov
Cijfers tot en met 30 september 2026, uit de 10-Q ingediend op 4 november 2026
Zimmer Biomet sells knee and hip replacement implants and other devices for bone and joint surgery to hospitals, surgery centers, and surgeons.
Grade B
De balk onder de koers toont het cijfer op elke datum, alleen gebaseerd op de stukken die toen al openbaar waren.
Toont 2 van 41 kwartalen van de cijferhistorie van Zimmer Biomet Holdings, Inc.. De andere 39 lopen terug tot november 2016.